Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3489912rdf:typepubmed:Citationlld:pubmed
pubmed-article:3489912lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0439861lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0000097lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0030493lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0282151lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C0205227lld:lifeskim
pubmed-article:3489912lifeskim:mentionsumls-concept:C1883709lld:lifeskim
pubmed-article:3489912pubmed:issue3lld:pubmed
pubmed-article:3489912pubmed:dateCreated1986-11-18lld:pubmed
pubmed-article:3489912pubmed:abstractTextC57 black mice were injected repeatedly with maximal tolerated doses of 4 different chemical analogues of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), or its metabolite N-methyl-4-phenylpyridinium ion (MPP+), in order to assess their possible neurotoxicity for dopaminergic nigrostriatal neurons and their potential for causing idiopathic Parkinson's disease. The 4 analogues were the herbicide paraquat, reduced paraquat (having two N-methyl-tetrahydropyridine moieties), N-methyl-1,2,3,4-tetrahydroisoquinoline, and 2-methyl-1,2,3,4-tetrahydro-beta-carboline, the latter two compounds being possible endogenous neurotoxins. Contents of striatal dopamine, measured by high-performance liquid chromatography with electrochemical detection one month after injections were completed, were not depleted by any of these 4 compounds in mice. They might conceivably prove more neurotoxic in primates.lld:pubmed
pubmed-article:3489912pubmed:languageenglld:pubmed
pubmed-article:3489912pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3489912pubmed:citationSubsetIMlld:pubmed
pubmed-article:3489912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3489912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3489912pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3489912pubmed:statusMEDLINElld:pubmed
pubmed-article:3489912pubmed:monthSeplld:pubmed
pubmed-article:3489912pubmed:issn0304-3940lld:pubmed
pubmed-article:3489912pubmed:authorpubmed-author:PerryT LTLlld:pubmed
pubmed-article:3489912pubmed:authorpubmed-author:JonesKKlld:pubmed
pubmed-article:3489912pubmed:authorpubmed-author:VICHAAlld:pubmed
pubmed-article:3489912pubmed:authorpubmed-author:YongV WVWlld:pubmed
pubmed-article:3489912pubmed:issnTypePrintlld:pubmed
pubmed-article:3489912pubmed:day12lld:pubmed
pubmed-article:3489912pubmed:volume69lld:pubmed
pubmed-article:3489912pubmed:ownerNLMlld:pubmed
pubmed-article:3489912pubmed:authorsCompleteYlld:pubmed
pubmed-article:3489912pubmed:pagination285-9lld:pubmed
pubmed-article:3489912pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:meshHeadingpubmed-meshheading:3489912-...lld:pubmed
pubmed-article:3489912pubmed:year1986lld:pubmed
pubmed-article:3489912pubmed:articleTitleParaquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.lld:pubmed
pubmed-article:3489912pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3489912pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3489912lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3489912lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3489912lld:pubmed